Dupixent (dupilumab)

pCPA File Number: 21501

Negotiation Status:

Concluded without agreement

Indication(s):

Asthma

Sponsor/Manufacturer:

Sanofi Genzyme Canada

CDA-AMC Project Number:

SR0667-000

pCPA Engagement Letter Issued:

2021-11-01

Negotiation Process Concluded:

2022-06-28